- The perils of portliness: causes and consequences of visceral adiposityC T Montague
Cardiovascular and Gastrointestinal Discovery Research Department, AstraZeneca Pharmaceuticals, Macclesfield, UK
Diabetes 49:883-8. 2000..Here we attempt to summarize the growing body of data relevant to these key areas and, in particular, to illustrate how recent advances in adipocyte biology are providing the basis for new pathophysiological insights...
- Adipose depot-specific effects of PPAR gamma agonists: a consequence of differential expression of PPAR gamma in adipose tissue depots?Carl T Montague
AstraZeneca Pharmaceuticals, Macclesfield, UK
Diabetes Obes Metab 4:356-61. 2002